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Frances Bunn1*, Anne-Marie Burn1, Claire Goodman1, Greta Rait2, Sam Norton3, Louise Robinson4,
Johan Schoeman5 and Carol Brayne6Abstract
Background: Evidence suggests that amongst people with dementia there is a high prevalence of comorbid
medical conditions and related complaints. The presence of dementia may complicate clinical care for other
conditions and undermine a patient’s ability to manage a chronic condition. The aim of this study was to scope the
extent, range and nature of research activity around dementia and comorbidity.
Methods: We undertook a scoping review including all types of research relating to the prevalence of
comorbidities in people with dementia; current systems, structures and other issues relating to service organisation
and delivery; patient and carer experiences; and the experiences and attitudes of service providers. We searched
AMED, Cochrane Library, CINAHL, PubMed, NHS Evidence, Scopus, Google Scholar (searched 2012, Pubmed
updated 2013), checked reference lists and performed citation searches on PubMed and Google Scholar (ongoing
to February 2014).
Results: We included 54 primary studies, eight reviews and three guidelines. Much of the available literature relates
to the prevalence of comorbidities in people with dementia or issues around quality of care. Less is known about
service organisation and delivery or the views and experiences of people with dementia and their family carers.
There is some evidence that people with dementia did not have the same access to treatment and monitoring for
conditions such as visual impairment and diabetes as those with similar comorbidities but without dementia.
Conclusions: The prevalence of comorbid conditions in people with dementia is high. Whilst current evidence
suggests that people with dementia may have poorer access to services the reasons for this are not clear. There is a
need for more research looking at the ways in which having dementia impacts on clinical care for other conditions
and how the process of care and different services are adapting to the needs of people with dementia and
comorbidity. People with dementia should be included in the debate about the management of comorbidities in
older populations and there needs to be greater consideration given to including them in studies that focus on
age-related healthcare issues.
Keywords: Dementia, Comorbidity, Diabetes, Stroke, Visual impairment, Scoping reviewBackground
World-wide there are an estimated 35.6 million people
with dementia. By 2050 it has been estimated that this
number will rise to more than 115 million [1]. Demen-
tia is primarily a disease of old age and it often coexists
with other conditions of old age. Evidence suggests
that amongst people with dementia there is a high* Correspondence: f.bunn@herts.ac.uk
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unless otherwise stated.prevalence of comorbid medical conditions and related
complaints [2-5]. In addition, there is evidence to support
an association between the dementia syndrome includ-
ing Alzheimer’s disease and cardiovascular risk factors,
such as hypertension and hypercholesterolaemia [6,7].
Comorbidity amongst people with dementia presents
particular challenges for primary and secondary care.
Certain comorbid medical conditions may exacerbate
the progression of dementia [8]. For example, cognitive
decline may be accelerated in older people with type 2
diabetes [9,10]. Moreover, the presence of dementia maytd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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conditions and be a key factor in how patients’ needs are
anticipated and specialist and emergency services are used
[11,12]. It may also undermine patients’ abilities to self-
manage chronic conditions and engage in health mainten-
ance activities [13]. Despite this, little is known about the
effects of comorbidity on processes and quality of care,
patient experience, or how services are adapting to address
the particular needs of this population [14].
A review of qualitative research on the experience of
diagnosis and treatment of dementia [15] found very little
evidence relating to the experiences of people diagnosed
with dementia who have an accompanying comorbid con-
dition. There is also a lack of research on patients’ views
on the ways in which multiple conditions affect their
health, well-being and clinical care [16]. The aim of this
review was to identify the extent, range and nature of
research activity relating to dementia and comorbidity, in
particular the prevalence of co-morbidity amongst people
with dementia, systems and structures that currently exist
for the care of people with dementia who have comorbid
medical conditions, and the experiences of people with
dementia who have comorbid medical conditions and
their family carers.
Methods
The scoping review was guided by Arksey and O’Malley’s
methodological framework [17,18] which includes: identi-
fying the research question; searching for relevant studies;
selecting studies; charting the data and collating and sum-
marising and reporting the results. This approach allowed
us to incorporate a range of study designs and address
questions beyond those related to treatment efficacy.
Whilst the scoping review has a number of similarities to
a systematic review it does not typically involve quality
assessment and findings are reported in a narrative format
[19,20]. The inclusion criteria and methods for the review
were pre-specified in a protocol [21]. The protocol was
externally peer reviewed as part of the National Institute
for Health Research (NIHR) funding process.
Identifying the research question
Inclusion criteria
We included studies involving people with dementia who
had an additional comorbid health condition. Although
we included all types of comorbidities there was a particu-
lar focus on three exemplar comorbid medical conditions;
diabetes, stroke and visual impairment. These three condi-
tions were chosen because they are common in older
people, generally involve some form of external moni-
toring and require collaboration between primary and sec-
ondary care. Moreover, they may exacerbate or influence
the progression of dementia and management of these
conditions; in particular, self-management is likely to becomplicated by the presence of dementia [13]. We focused
on community dwelling participants and excluded studies
in long term care settings. We looked for studies relating
to the prevalence of comorbidities in people with demen-
tia or cognitive impairment; current systems, structures
and other issues relating to service organisation and deliv-
ery; patient and carer experiences; and the experiences
and attitudes of service providers. We included all study
types including systematic reviews, randomised controlled
trials (RCTs), controlled studies, observational studies and
qualitative studies using any recognisable qualitative meth-
odology. In addition, we included non-research items,
such as clinical guidelines. We excluded studies dissemi-
nated in languages other than English.
Searching for relevant studies
We searched for a representative range of material which
provided an overview of current knowledge and that iden-
tified some key examples of developments in the organisa-
tion and delivery of care for people with dementia and
comorbid conditions. We included published and unpub-
lished literature with no date restrictions. Studies were
identified by computerised searches of AMED, Cochrane
Library (including CENTRAL, CDSR, DARE, HTA),
CINAHL (EBSCO Publishing) (1980 to 2012), PubMed
(1950 to 2013), NHS Evidence (searched September 2012)
and Scopus (1966 to 2012). The electronic search strategy
was developed by an experienced information scientist
with input from the project team. An example of the
search query for PubMed is given in Table 1. In addition,
we employed extensive lateral search techniques, such as
checking reference lists, performing key word searches in
Google Scholar and using the ‘cited by’ option in PubMed.
We also contacted experts and those with an interest in
dementia, such as the Alzheimer’s Society, the Thomas
Pocklington Trust, Royal National Institute for the Blind,
Diabetes UK, the Stroke Association, and the Dementia
and Sight Loss Interest Group. Such lateral strategies have
been shown to be particularly important for identifying
non-randomised studies [22]. The original electronic data-
base searches were conducted in September 2012, with
the PubMed search updated in November 2013 and lateral
searches updated in February 2014.
Selecting studies and charting the data
Electronic search results were downloaded into EndNote
bibliographic software and, where possible, duplicates
deleted. Two authors (FB and AB) independently screened
titles and abstracts identified by the electronic search and
applied the selection criteria to potentially relevant papers.
Data were extracted by one author using a standardised
checklist and checked by a second. Any disagreements
were resolved by consensus or by discussion with a third
author (CG). Where results of a study were reported in
Table 1 Search strategy used in PubMed
Search component Search terms
#1 Dementia and diabetes ((Dementia OR Alzheimer OR cognitive impairment OR delirium) AND (Diabetes OR blood glucose self-monitoring)
(Self management OR Self Care OR Self monitoring OR Service delivery OR Service organization OR Activities of daily
living OR Caregivers OR Quality Assessment OR Quality OR Quality Indicators OR Quality of life OR Disease Progression
OR Behaviour OR Impact OR Geriatric Assessment OR Severity of Illness OR Nursing Assessment OR Interprofessional OR
Standard of Care OR Risk Factors OR Treatment outcome OR patient Experience) AND (Humans[Mesh]))
#2 Dementia and stroke (Dementia[ti] OR Alzheimer[ti]) AND (stroke OR cerebrovascular OR CVA OR cerebrovascular disorders) AND (Self
management OR Self Care OR Self monitoring OR Service delivery OR Service organization OR Activities of daily living
OR Caregivers OR Quality Assessment OR Quality OR Quality Indicators OR Quality of life OR Disease Progression OR
Behaviour OR Impact OR Geriatric Assessment OR Severity of Illness OR Nursing Assessment OR Interprofessional OR
Standard of Care OR Risk Factors OR Treatment outcome OR patient Experience) AND (Humans[Mesh]))
#3 Dementia and visual
impairment
(Dementia OR Alzheimer OR cognitive impairment OR delirium) AND (Eye diseases OR vision disorders OR Blindness
OR visually impaired OR Nystagmus OR retinopathy OR macular degeneration OR glaucoma or cataract) AND (Self
management OR Self Care OR Self monitoring OR Service delivery OR Service organization OR Activities of daily living
OR Caregivers OR Quality Assessment OR Quality OR Quality Indicators OR Quality of life OR Disease Progression OR
Behaviour OR Impact OR Geriatric Assessment OR Severity of Illness OR Nursing Assessment OR Interprofessional OR
Standard of Care OR Risk Factors OR Treatment outcome OR patient Experience)
#4 Dementia and
comorbidity
((Dement*[ti] OR Alzheimer*[ti]) AND ((comorbidity OR co-morbidity OR comorbid OR “other medical conditions” OR
“other chronic disease*” OR multimorbidity[ti] OR multi-morbidity[ti] OR multiple disease*[ti] OR multiple morbid*[ti]
OR polypathology[ti] OR associated disease*[ti] OR associated disorder*[ti]) OR co-existence[ti] OR co-existing[ti] OR
concomitant[ti] OR co-occurring[ti]))
#5 #1 OR #2 OR #3 OR #4 OR #5
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and marked the publication with the most complete data
as the primary reference; the other papers describing the
same study were classified as associated papers. Data ex-
tracted included type of item (for example, empirical study,
review, guideline), aims/research questions, methods, study
focus, participants, setting and relevant outcome data (for
example, rates of comorbidities, access to treatment,
patient and carer views).
Reporting the results
Studies were grouped into the following categories: 1)
prevalence, 2) quality of care, 3) views and experiences
(patients, carers and health care professionals) and 4)
health service organisation and delivery. All data are
reported in a narrative format.
Results
Description of studies
We included 74 papers, 65 of which were classified as
primary references [2,5,11,13,23-83] and nine as associated
papers [84-92]. Study characteristics are summarised in
the list below and details of individual studies, including
the links between primary and associated papers, in
Additional file 1. An overview of the selection process
can be seen in Figure 1. We included studies conducted in
12 different countries but 63% were from the UK and
USA; the majority were observational, qualitative or re-
views. Participants were predominantly community dwell-
ing (some had mixed samples and included those living in
long-term care) and the majority were older than 70;
ethnicity was not reported in 55% (n =36) of studies. In
60% of studies (n =39) participants all had dementia, in25% (n =16) they had mixed populations including people
with dementia, cognitive impairment and delirium and in
15% (n =10) they had cognitive impairment. A total of 39
studies (60%) focused on a single comorbidity and the rest
on more than one comorbidity or general comorbidity/
multimorbidity (for example papers relating to the experi-
ences of people with dementia in acute hospitals). We
found more evidence relating to diabetes or visual impair-
ment than relating to stroke, and most of the evidence
related to the prevalence and quality of care with less on
service organisation and delivery or views and experiences
of patients, carers or health care professionals.
Overview of study characteristics
Study informationa
Year of publication
Range 1989 to 2014
Country
 UK number = 23
 USA number = 18
 Europe (not UK) number = 8
 Australia number = 3
 Canada number = 4
 Japan number = 2
 International reviews/guidance number = 7
Type of study
 Case control number = 9
 Cohort study number = 12
 Cross sectional number = 15
 Guideline/policy document number = 3
 Qualitative number = 7
 RCT number = 3
Figure 1 Flow chart study selection process.
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 Review/scoping number = 8
 Other number = 5
Areas covered in studyb
 Prevalence number = 28
 Service organisation and delivery number = 16
 Views and experiences number = 12
 Quality of care number = 21
Setting
 Hospital/outpt clinic number = 30
 Community number = 12
 Primary care number = 7
 Mixed community/residential care number = 5
 Population based sample number = 8
Type of participants
Type of cognitive impairment
 Dementia number = 40 Cognitive impairment (including dementia and
delirium) number = 8
 Mixed population including people with dementia
and MCI number = 10
 MCI = 9
Age
 Range 43 to 102 but majority over 70
 Of 38 studies that gave a mean age – majority had
mean age in 70s
Ethnicity
 Not specified number = 36
 White (or majority white) number = 14
 Mixed number = 3
 Mixed but majority black number = 2
 NA (for example, review) number = 10
Comorbidities included in studiesb
 Diabetes number = 15
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 Visual impairment number = 14
 Other comorbidities number = 7 (for example,
cancer, MI)
 General comorbidity number = 12
 More than one comorbidity (but includes one of
our target conditions) number = 14
Type of dementia
 Alzheimers number = 8
 Mixture of different types number = 4
 Not reported in rest
Prevalence
Our main aim was to look at the prevalence of comorbidity
(in particular stroke, diabetes and visual impairment) in
people with dementia. Thirteen studies provided data about
the prevalence of comorbidities in people with dementia
[2,5,26,46,55,56,58,64,65,75,80-82] and two the prevalence
of comorbidities in people with mild cognitive impairment
(MCI) [36,72] (see Table 2). The representativeness of the
samples varied. Four studies included population based
samples [36,55,56,72], six recruited populations from pri-
mary care databases [2,5,26,58,64,82] and five used samples
from hospitals or out-patient clinics [46,65,75,80,81] [see
Additional file 2]. Data were collected from medical records
in six studies [26,46,64,75,80,82], from clinical examination
or interviews in six [2,36,55,56,65,72] and from a mixture
of medical records and clinical examination in three
[5,58,81]. The presence of dementia and comorbid med-
ical conditions was assessed using a variety of measures
[see Additional file 3].
We also included a further eight studies that reported
the prevalence of dementia in people with one of our
three target comorbidities [30,38,39,47,66,78,79,83] (see
Table 3). Three studies included samples from out-
patient clinics [38,78,79], one data from an RCT in
primary care [47], two research administration or health
claims databases in the USA [39] and Australia [83], one
from a stroke register in Canada [66] and one a popula-
tion derived community-based sample in Australia [30].
Three collected data from medical or database records
[39,66,83] and the rest from face to face interviews or
clinical examinations.
Prevalence of target comorbidities in people with dementia
Diabetes
Twelve studies reported the prevalence of diabetes in popu-
lations of people with dementia [5,26,46,55,56,58,64,65,80,81]
or MCI [36,72]. Prevalence rates varied from 6% to 39%.
The two largest studies which both involved participants
from national primary care data sets in the UK, one from
Scotland [26] and one from the UK (primarily England)
[64], reported similar prevalence rates of 13% [26] (personal
communication B Guthrie) and 14% [64]. Five studiescompared rates of diabetes in those with and without de-
mentia. Of those, three studies with samples recruited from
primary care databases, two from the USA and one from
the UK, found similar rates between groups [5,58,64] and a
study in hospital inpatients in Switzerland found no signifi-
cant differences in rates of diabetes mellitus between those
with and without dementia [81]. In contrast, a study of
hospital in-patients in the UK found significantly fewer
people with dementia diagnosed with type-2 dementia than
controls without dementia [46].
Stroke
Nine studies reported the prevalence of stroke in people
with dementia [5,26,46,55,56,58,64,80,81] and two in people
with cognitive impairment [36,72]. Prevalence rates varied
from 3% in hospitalised older people in the UK [46] to 34%
in a sample of urban and rural community dwelling people
with cognitive impairment in the USA [36]. Two studies
used records from large primary care databases in the UK,
one reported that rates of stroke in people with dementia
were 19% [26] and the other that rates of cerebrovascular
disease (including stroke) were 29% [64]. Five studies com-
pared rates of stroke in people with and without dementia.
Three found no significant difference in the prevalence of
stroke [5,46,81], but one study of hospital inpatients found
that stroke was more common in people with dementia
[56] and a primary care based study in the UK found a
greater prevalence of cerebrovascular disease in people with
dementia [64].
Visual impairment
Four studies reported the prevalence of some form of vis-
ual impairment in people with dementia, including all eye
diseases [80], glaucoma [46,55] and cataracts [55,82]. Dif-
ferences in the populations studied and the way cases were
identified make comparisons across studies difficult. Two
studies compared rates of glaucoma in people with
dementia and those without; prevalence in people with de-
mentia was lower in a population sample in Finland [55]
but not different in hospital inpatients in a retrospective
case control study in the UK [46]. Two studies compared
rates of cataracts. A large primary care cohort study in the
UK found a lower incidence rate for cataracts in people
with AD than controls [82] but a smaller population-
based study in Finland reported no difference in the rates
of cataracts [55].
Prevalence of dementia in people with stroke, diabetes
and visual impairment
Five studies looked at the prevalence of dementia or cogni-
tive impairment in populations of people with diabetes. In a
large population-based study in the USA, 13% of people
with diabetes had dementia or cognitive impairment [39]
compared with 23% in a sample recruited through primary
Table 2 Prevalence of diabetes, visual impairment and stroke in people with dementia
Study and
country
Study type Dementia/CI Control/
comparison
Eligibility criteria Recruited from Number
whole sample
Number
dementia/CI
Diabetes
)
Stroke
(%)
VI
(%)
Notes
Barnett [26]
UK (Scotland)
Cross-sectional Dementia NA Alive, permanently
registered with a
participating practice
Primary care –
national dataset
1751841 11139 .3 18.8 3.8 VI is blindness/low
vision
Doraiswamy
[2]
Cross-sectional Dementia NA Diagnosis of Alzheimer’s
disease, 50 or over
Community health
care sites
679 679 - - 61% had three or
more comorbidities,
30% had vascular or
heart disease. Sample
included mixture of
community dwelling
and long-term care
Feil [36] USA Longitudinal
cross sectional
CI No CI Geographically defined,
65 and over
Population derived
sample
7482 1774 34 -
Heun [46] UK Retrospective
case control
Dementia No dementia Diagnosis of AD, 70+,
in-patient care for at
least 24 hours
Hospital in-patients 72878 634 3 1 VI is glaucoma. Diagnosis
of diabetes less common
in those with AD than
controls RR 0.7 (95% CI
0.5 to 0.9). No significant
difference in prevalence
of ischemic stroke RR
1.3 95% CI 0.9 to 2.0, or
glaucoma RR 2.0 (1.0
to 4.3)
Jara [82] UK Retrospective
cohort
Dementia No dementia 64 and over, at least 24
months continuous
enrolment, no cataract
diagnosis at baseline
Primary care –
national dataset
650325 8124 - - Lower rate of any
cataract in AD group
compared to controls
HR 0.52 (95% CI 0.47
to 0.58)
Löppönen
[55] Finland
Cross-sectional Dementia NA Geographically defined,
65 and over
Population based 1260 112 24 29 PWD less likely to be
diagnosed with
glaucoma OR 0.36; 95%
CI 0.15 to 0.86), no
difference in rates of
cataract p =0.287
Lyketsos
[56] USA
Case–control Dementia/CI No dementia/CI Geographically defined,
65 and over
Population based 695 374 16 - Stroke more common
in people with
dementia p <0.001
McCormick
[58] USA
Case–control Dementia/CI No dementia/CI Aged 60 and over,
members of HMO,
geographically defined
Population derived
(from HMO database)
154 154 3a 10 Visual problems less
common in PWD (10%
versus 24%)
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Table 2 Prevalence of diabetes, visual impairment and stroke in people with dementia (Continued)
Rait [64] UK Cohort Dementia No dementia 60 and over with first
code for dementia
during study period,
at least six months data
Primary care –
national dataset
135174 22529 14 29a - No difference in
prevalence of diabetes
(13.9% versus 14.5%)
but cerebrovascular
disease more common
in people with dementia
(29.3% versus 13.3%)
Sakurai [65]
Japan
Cross
sectional
Dementia NA Dementia or MCI Memory clinic 160 160 - - Dementia and CI
Schubert [5]
USA
Cross-sectional Dementia No dementia 65 and older, seen primary
care physician within two
years. Excluded nursing
home residents, non-English
speaking
Primary care 3013 107 10 - No significant
difference in prevalence
of DM (P =0.19) or stroke
(P =0.89) between those
with and without
dementia
Stephan [72]
UK
Cross-sectional MCI No MCI 65 and over Population based 13004 1486 19 -
Uhlmann[75]
USA
Case control Dementia No dementia 65 and over, English
speaking, eighth-grade
or higher education,
ability to complete
audiometric evaluation
Adult medicine
clinic
174 87 t
ven
not
given
- Prevalence of VI
significantly higher in
cases than controls
(OR 2 95% CI 1.2-3.4).
Zamrini [80]
USA
Case control Dementia NA Probable AD, black or
white (white participants
matched non randomly
to black participants)
Memory clinic
database
334 334 9 10 Includes all eye
diseases
Zekry [81]
Switzerland
Cohort Dementia No dementia 75 and over. Excluded:
terminal illness, disorders
interfering with psychometric
assessment
Hospital in-patients 349 188 22 - MCI + dementia
aCerebrovascular disease; − = not given. CI, cognitive impairment; MCI, mild cognitive impairment; PWD, people with dementia; VI, visual impairment.
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Table 3 Prevalence of dementia in people with stroke, diabetes and visual impairment
Study and country Type of study Type of population Control/comparison Eligibility criteria Recruited from Number whole
sample
Number dementia/CI
Bruce [30] Australia Longitudinal
cross sectional
DM NA Defined by post-code, 70 years
or older, diabetes
Patients living in catchment
area of hospital (63% of eligible
patients recruited)
223 34 (15.3%)
Feil [38] USA Longitudinal
cross-sectional
DM NA Diagnosis of type 2 diabetes,
60 years or older
Geriatric clinic 51 23 (45% CI)
Feil [39] USA Cross-sectional DM NA Veterans aged 65 and older
with diabetes mellitus
Research administration database
(Veterans Health Administration)
497000 65107 (13% dementia/CI)
Hewitt [47] UK Questionnaire DM NA Type 2 diabetes, aged 75 and
older, not resident in nursing
homes
Data from RCT in Primary Care 1047 235 (22.5% dementia/CI)
Zhang [83] Australia Retrospective
cohort study
DM NA Veterans, 65 and older, received
prescription for diabetes in
previous six months
Health claims database 17095 4.4%
Saposnik [66] Canada Retrospective
cohort study
Stroke and dementia Stroke no dementia 18 years and older, first
ischemic stroke
Stroke register (included patients
admitted to 12 regional stroke
centres in Ontario)
10658 966 (9.1%)
Whitson [78] USA Cross-sectional VI (macular disease) NA 65 and older, macular disease
diagnoses
Low Vision Rehabilitation clinic 101 19 (19%)
Yochim [79] Case series VI (glaucoma) NA 50 and older, diagnosis of
glaucoma
Glaucoma clinic 41 44% (MCI)
CI, Cognitive impairment; DM, diabetes mellitus MCI, mild cognitive impairment; RCT, randomised controlled trial; VI, visual impairment.
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dementia in people with visual impairment recruited via
eye clinics. In one [78] 19% of people with macular disease
had dementia and in the other [79] 20% of people with
glaucoma had memory impairment and 22% impaired
executive functioning. One study looked at the prevalence
of dementia amongst people who had had a stroke. Of
more than 10,000 people on a stroke register 9% were
reported to have dementia.
Quality of care
We categorised 23 studies as relating to quality of care in
some way, 11 of which compared access to treatment or
receipt of services in groups with and without dementia.
Ten of the 11 studies found some evidence that people
with dementia were less likely to receive the same quality
of care or access to services compared to those without
dementia. For example, studies found that people with de-
mentia were less likely to receive monitoring for diabetes
related problems [32,74] and had reduced access to treat-
ment, such as intravenous thrombolysis for stroke [66],
surgery for cataracts [45], treatment for age-related macu-
lar degeneration (AMD) [11,33] or services for diabetes
[77,83]. More details can be seen in Table 4. A German
study reported that older people with a greater number of
comorbidities were less likely to receive cholinesterase
inhibitors for dementia [48] and a Canadian study found
evidence that pain is undertreated in people with dementia
and arthritis [25].
In addition, there was evidence that having dementia
or cognitive impairment impacts on a person’s ability to
undertake self-care management. For example, people
with dementia and diabetes had problems understanding
their condition, managing medication and monitoring
their blood glucose [13,29,37,38,47].
Views and experiences
We included 11 studies looking at views and experiences
of people with dementia, their family carers and health
care professionals. Six were qualitative [27,37,54,62,70],
one was a mixed study including a review and qualitative
study [42], two were reviews [28,34] and two were ques-
tionnaire studies [29,47]. Three studies focused on people
with dementia and diabetes [29,37,47], two visual impair-
ment [28,54], one deafness [24], one cancer [27] and four
on the needs of people with dementia in general hospitals
[34,42,62,70].
Literature on the experiences of older people with
dementia in acute general hospitals has highlighted short-
comings in the care provided, attitudes and training of staff,
the physical environment and problems with care cultures
[34,42,62]. Poor communication is a major barrier to the
provision of good care for people with dementia and a
comorbid health condition [34,42,54]. Practitionersreported that they found it difficult to communicate with
people with dementia and communication difficulties are
compounded when they have additional comorbidities
which make communication difficult, such as hearing loss
or sight loss [24,27,54]. There were also problems with
communication between different professionals and spe-
cialist teams with a lack of coordinated working between
practitioners in different specialities [54]. A lack of appro-
priate knowledge and training was also a major barrier,
with those working in acute care hospitals [42], palliative
care [27] and diabetes [39] lacking knowledge about
dementia. Conversely, those in dementia services may lack
awareness about how to support people with dementia
and visual impairment [54,88].
A qualitative study involving the views of 21 caregivers
of people with dementia and type 2 diabetes found that
behavioural and psychological symptoms of dementia
disrupted diabetes care. In addition, carers felt that they
received inadequate support in planning their relatives
care, that their contribution to managing their relatives
care was not always recognised and that they were often
excluded from decision making [37].
Service organisation and delivery
Guidelines and care pathways
Guidance on the care of older people with diabetes high-
lights the need to balance the benefits of diabetes treatment
while minimising the risk in people with dementia [49]
as this group may be at increased risk of hypoglycaemia
[49,68] and guidance from the College of Optometrists
states that when examining patients with dementia
optometrists have a duty to carry out whatever tests are
necessary to determine the patients’ need for vision care
[31]. However, most guidelines are condition specific and
generally fail to take into account multimorbidity or the
needs of people with dementia [38,47,72,77,84,88].
A recent review identified 16 guidelines/position state-
ments or standards (from the UK, USA and Australia)
for the care of people with dementia but these generally
focused on standards for providing optimal care for
older people with cognitive impairment in acute hospi-
tals or specific issues, such as hydration, nutrition or
wandering [23]. They did not cover issues relating to the
care of people with dementia and specific medical condi-
tions (such as diabetes). Moreover, most models of prac-
tice for work with people with dementia do not mention
visual impairment [88].
Models of care for older people with cognitive impairment
A number of initiatives have been developed to improve
the care of older people with dementia in acute hospitals,
including liaison psychiatric services [50,73] or specialist
units that combine medical and mental health care for
older people [41,44]. Much of the work in this area is
Table 4 Impact of dementia and medical comorbidities on quality of care and access to treatment
Study ID Country Comorbidity Study type Number of participants Aspect of
quality of care
Evidence that
care is different?
Reported differences in care/treatment
Connolly [92] UK DM, Stroke Cross sectional 700 PWD (compared to people without
dementia on QOF register)
Monitoring and
treatment
Yes PWD -significantly lower on 73% of QOF indicators;
including peripheral pulses check, neuropathy
testing, cholesterol measures for stroke.
Curtis [33] USA VI (AMD) Retrospective
cohort
284380 Treatment Yes PWD significantly less likely to receive anti-VEGF RR
0.88 (95% CI 0.88 to 0.89)
Guijarro [45] Spain VI, general Cohort 40482 Treatment Yes PWD had some procedures less frequently than
those without dementia. For example,cataract
surgery (P <0.001), hernia repair, orthopaedic
surgery
Keenan [11] UK VI (AMD) Cohort 65894 (AMD cohort, 168092 dementia cohort) Treatment Yes PWD significant decrease in likelihood of hospital
admission for AMD P <0.001
Löppönen [55] Finland VI, general Cross sectional
(survey)
1260 older people (112 PWD) Diagnosis and
treatment
Yes PWD -more undiagnosed diseases compared to those
without dementia (P =0.041) , less likely to be
diagnosed with glaucoma (P =0.022)
Müther [60] Germany DM,
hypertension
Retrospective
matched control
216 PWD, 216 matched controls Treatment No No significant differences in treatment for those
with and without dementia. PWD more likely not to
receive medication for hypertension or be treated
with low-priced medications (not significant)
Saposnik [66] Canada Stroke Cohort 877 with pre-existing dementia Treatment Yes Patients with pre-existing dementia less likely to receive
intravenous thrombolysis.
877 controls (no pre-existing dementia)
Sloan [69] USA Acute MI Cross sectional 5851 admitted for AMI with dementia, 123241
admitted for AMI without dementia
Treatment Yes PWD less likely to have a range of invasive
procedures compared to those without a history of
dementia
Thorpe [74] USA DM, VI Cohort 288805 (44717 PWD) Monitoring Yes PWD less likely to receive HbA1c tests (73% versus
81%), LDL-C tests (61% versus 79%), and eye
examinations (52% versus 63%).
Vitry [77] Australia DM Cohort 20134 veterans with diabetes (includes people
with dementia/CI but numbers not clear)
Treatment Yes Presence of dementia associated with decreased
likelihood of treatment intensification (for example,
addition of antidiabetic medicine or switch to
insulin/different medication)
Zhang [83] Australia DM, VI Cohort 17095 veterans with and without diabetes
(4.4% on dementia medication)
Treatment,
access to
services
Yes Patients receiving medications prescribed for
dementia less likely to use diabetic and optometry⁄
ophthalmology services.
AMD, age-related macular degeneration; AMI, acute myocardial infarction; CI, cognitive impairment; DM, diabetes mellitus; HbA1c, glycosylated hemoglobin; LDL-C, low-density lipoprotein cholesterol PWD, people with
dementia; QOF, quality of life; VEGF, vascular endothelial growth factor; VI, visual impairment.
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health unit for people with dementia has recently been eval-
uated in an RCT [44]. They found no difference between
the specialist unit and standard care on general medical
wards for their primary outcome (days spent at home) but
there were significant differences in process items in favour
of the intervention, and family carers were more satisfied
[44]. However, the study excluded patients with clinical
needs for specialist services, such as surgery or stroke units.
A scoping review of interventions for cognitively
impaired older people in emergency departments found
no evaluations of organisational or system level interven-
tions and little evidence of appropriate interventions
[61]. We found no evaluations of interventions aimed
specifically at our three target comorbidities, although a
retrospective analysis of stroke patients suggested that
cognitively impaired patients benefit from admission to
an acute rehabilitation stroke unit [63].
Discussion
We included 54 primary studies, eight reviews and two
guidelines that addressed issues around dementia and
comorbidity. We found evidence of a lack of continuity
in health care systems and structures for people with de-
mentia and comorbidity, with little integration or com-
munication between different teams and specialities [54].
Moreover, many models of care are focused on single
diseases and do not take into account the needs of those
with multimorbidity [26,84] or of their family carers. We
found a number of studies reporting prevalence for our
three target comorbidities. Whilst heterogeneity in the
populations and differences in the way that conditions
were ascertained make comparisons across studies diffi-
cult the data do suggest that rates of diabetes in people
with dementia may be between 13 and 20 percent and of
stroke between 16 and 29 percent.
We undertook a scoping review rather than a systematic
review. A limitation of such an approach is that the review
does not include an assessment of the quality of the in-
cluded studies or evaluate the effectiveness of interventions.
However, evaluative research in this area is limited and our
aim was to examine the extent, range and nature of
research activity around patient and carer need, health care
provision and service organisation for people with dementia
and comorbidity. Moreover, whilst we did not undertake
formal quality assessment we did extract methodological
information on study populations and data collection
methods that aided in the interpretation of the evidence.
We set out to include a representative rather than exhaust-
ive range of literature and it is possible that we have missed
relevant studies or guidelines. However, our search strategy
was guided by systematic review methodology and we
employed extensive database and lateral searches. We are
confident, therefore, that this scoping review provides acomprehensive summary of current evidence relating to
dementia and comorbidity for people living in the com-
munity, particularly in relation to diabetes, stroke and vis-
ual impairment. We did, however, exclude studies in care
homes where there are likely to be considerable levels of
dementia and comorbidity. Moreover, the majority of our
studies focus on single comorbidities and the review does
not cover the presence of multiple conditions. The
support that people with dementia and multiple health
conditions need may be different than those with less
complex needs. Further studies are needed to understand
the complexity within multiple comorbidities.
To our knowledge, this is the first review of research
and practice on co-morbidity in dementia. Most research
on multimorbidity has been concerned with its effect on
physical functioning and its measurement, with little re-
search investigating the effect on processes of care or what
constitutes ‘best care’ for these patients [14]. Moreover,
qualitative research on dementia has tended to focus on
the experience of living with dementia as a single disease
[15]. This review sets out current research and knowledge
about the impact of comorbidities on people diagnosed
with dementia and what is known about their experiences
of health care.
This review suggests that significant numbers of people
with dementia have a comorbid health condition, such as
diabetes or stroke. This has serious implications for the
way that specialist services for conditions such as diabetes
are delivered for people with dementia. Despite these high
levels of comorbidity in people with dementia there was
evidence that they did not have the same access to treat-
ment and monitoring for conditions such as visual impair-
ment and diabetes as those with similar comorbidities but
without dementia. There may be a variety of factors that
contribute to this finding. For example, people with de-
mentia may be less likely to attend regular appointments
or to notice or report relevant symptoms and they may be
more reliant on carers to manage and facilitate appoint-
ments [11]. It is also possible that clinicians may be more
reluctant to investigate and treat patients with dementia
either because of the difficulties involved in securing
patient cooperation or because treatments are considered
inappropriate for older patients with multimorbidity. In
addition, if the dementia is symptomatic (such as the be-
havioural and psychological symptoms associated with
dementia) then dementia may become clinically dominant
and detract from the management of conditions such as
diabetes mellitus [93,94].
Much of the available literature relates to the preva-
lence of comorbidities in people with dementia or issues
around quality of care. There is less evidence relating to
service organisation and delivery, patient and carer pre-
ferences or the decision making processes of clinicians
involved in their care. Whilst there is literature relating to
Bunn et al. BMC Medicine 2014, 12:192 Page 12 of 15
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this is focused on in-patient care for patients who would
otherwise be admitted to a general medical ward and does
not provide guidance on the management of specific con-
ditions (such as diabetes or stroke) in people with demen-
tia. In addition there is little guidance on the care of
people with dementia and long-term conditions living in
the community. Family caregivers of people who have
dementia and other health conditions face great challenges
in managing both conditions and dealing with the impact
of accompanying behavioural and psychological symptoms
of dementia on care routines [37]. Despite this, little is
known about how family carers can best be supported, or
how health care services should adapt to address the
particular needs of this population.Recommendations for research
The review highlights significant gaps in the evidence.
There is currently a lack of research on the experiences
of patients and their family carers on living with de-
mentia and comorbid conditions. Even less is known
about healthcare providers experiences of managing
people living with dementia and comorbid health con-
ditions and how the presence of dementia influences
the care they receive for their comorbidity. These are
areas that are currently being explored in an NIHR
study on dementia and comorbidity [21]. In addition,
there is a need for more detailed epidemiological work
on the prevalence of comorbidities in people with demen-
tia and the appropriateness of treatment and referral for
this group. People with dementia should be included in
debate about the management of comorbidities in
older populations, and there needs to be greater con-
sideration given to including them in studies and trials
that focus on age-related healthcare issues. Equally,
dementia-specific studies need to consider the impact
of comorbidities on the experience of living and dying
with dementia.Conclusions
The prevalence of comorbid conditions in people with
dementia is high. Whilst current evidence suggests
that people with dementia may have poorer access to
services the reasons for this are not clear. There is a
need for more research looking at the ways in which
having dementia impacts on clinical care for other
conditions, how process of care and different services
can adapt to the needs of people with dementia and
comorbidity, and what interventions might improve
access to services and the physical health of people
with dementia. Clinical guidance should consider the
particular needs of those with dementia and comorbid
health conditions.Endnotes
aAll numbers refer to the numbers of studies not
individual participants.
bsome studies classified in more than one category.
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